181 results on '"Hillerdal, Gunnar"'
Search Results
2. Achieving Thoracic Oncology data collection in Europe: a precursor study in 35 Countries
3. A Multicenter Randomized Controlled Trial of Zephyr Endobronchial Valve Treatment in Heterogeneous Emphysema (TRANSFORM)
4. Pleuropulmonary lesions, ergotamines and asbestos exposure
5. First China-Japan joint asbestos symposium, Beijing, 16—17 July 1999
6. Mesothelioma: Cases Associated with Non-Occupational and Low Dose Exposures
7. Progression of Pleural and Parenchymal Disease on Chest Radiographs of Workers Exposed to Amosite Asbestos
8. Asbestos, asbestosis, pleural plaques and lung cancer
9. Intrabronchial stents in heterogenous emphysema : a highly selected material followed 5 years
10. Intrabronchial stents in heterogenous emphysema: a highly selected material followed 5 years
11. Treatment of Malignant Pleural Mesothelioma with Carboplatin, Liposomized Doxorubicin, and Gemcitabine: A Phase II Study
12. Screening for Mesothelioma: More Harm than Good?
13. Indolent Lung Cancers—Time for a Paradigm Shift: A Review
14. Malignant Mediastinal Tumor with Bone Formation - Mesothelioma or Sarcoma?
15. Diagnosis and Initial Management of Nonmalignant Diseases Related to Asbestos
16. Increased Risk for Cancer Following Sarcoidosis
17. Additional file 1: of Achieving Thoracic Oncology data collection in Europe: a precursor study in 35 Countries
18. Additional file 2: of Achieving Thoracic Oncology data collection in Europe: a precursor study in 35 Countries
19. Development of a multivariate prediction model for early-onset bronchiolitis obliterans syndrome and restrictive allograft syndrome in lung transplantation
20. Pleural changes and exposure to fibrous minerals
21. Sotrökslunga är en ny sjukdom i Sverige : Exponering för rök från biomassa är orsaken
22. Ex vivo evaluation of tumor cell specific drug responses in malignant pleural effusions
23. P1.03-008 Clinical Importance of Indolent Lung Cancers
24. P2.03a-013 Chemotherapy is Beneficial for Octogenarians with Non-Small Cell Lung Cancer (NSCLC)
25. P1.06-008 Non-Small Cell Lung Cancer in Octogenarians: Real-Life Clinical Practice; Characteristics, Therapy and Survival
26. Detection of Chlamydia pneumoniae on cytospin preparations from bronchoalveolar lavage in COPD patients and in lung tissue from advanced emphysema
27. Lung cancer among native and foreign-born Swedes : histopathology, treatment, and survival
28. Non-small Cell Lung Cancer (NSCLC) in Octogenarians in Clinical Practice
29. Non-small Cell Lung Cancer (NSCLC) in Octogenarians in Clinical Practice
30. Occupation and mesothelioma in Sweden: updated incidence in men and women in the 27 years after the asbestos ban
31. Chemotherapy Treatment of Elderly Patients (≥70 Years) with Non-Small Cell Lung Cancer : A Seven-Year Retrospective Study of Real-Life Clinical Practice at Karolinska University Hospital, Sweden.
32. Stereotactic Body Radiotherapy (SBRT) or Surgery in Early Stage (I & II) Non Small Cell Lung Cancer (NSCLC)
33. Surgery in Elderly Patients ( > 70 Years or Older) with Non-Small Lung Cancer (NSCLC). Impact of Adjuvant Chemotherapy
34. When small is better: volume reduction in severe emphysema
35. Chemotherapy Treatment of Elderly Patients (≥70 Years) with Non-Small Cell Lung Cancer: A Seven-Year Retrospective Study of Real-Life Clinical Practice at Karolinska University Hospital, Sweden
36. Pemetrexed and Gemcitabine Versus Carboplatin and Gemcitabine in Non-Small Cell Lung Cancer: A Randomized Noninferiority Phase II Study in One Center
37. One- to Four-Year Follow-Up of Endobronchial Lung Volume Reduction in Alpha-1-Antitrypsin Deficiency Patients : A Case Series
38. Treatment of Elderly (70 Years or Older) with Lung Cancer. A Four-Year Material in Clinical Practice from Karolinska University Hospital - Sweden
39. Lung Cancer Among Swedish and Imigrants. Incidens, Histopathology, Treatment and Survival
40. Treatment of Elderly Patients (< 70 Years) with Non-Small Cell Lung Cancer Given Chemotherapy. A Four-Year Material in Clinical Practice from Karolinska University Hospital Sweden
41. Home administration of maintenance pemetrexed for patients with advanced non-squamous non-small cell lung cancer: rationale, practicalities and phase II feasibility study design
42. Hyaluronan and N-ERC/Mesothelin as Key Biomarkers in a Specific Two-Step Model to Predict Pleural Malignant Mesothelioma
43. Slow-growing lung cancer as an emerging entity: from screening to clinical management.
44. Randomized phase II study of gemcitabine and carboplatin +/- sequential docetaxel in non-small cell lung cancer
45. Guidelines of the European Respiratory Society and the European Society of Thoracic Surgeons for management of Malignant Pleural Mesothelioma
46. Guidelines of the European Respiratory Society and the European Society of Thoracic Surgeons for the management of malignant pleural mesothelioma
47. Endemic malignant mesothelioma: exposure to erionite is more important than genetic factors.
48. Treatment of malignant pleural mesothelioma with liposomized doxorubicine : prolonged time to progression and good survival. A Nordic study
49. Multicentre Phase II Trial of Paclitaxel and Carboplatin with Concurrent Radiotherapy in Locally Advanced Non-small Cell Lung Cancer
50. Home administration of maintenance pemetrexed for patients with advanced non-squamous non-small cell lung cancer: rationale, practicalities and phase II feasibility study design
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.